|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
La Jolla Pharmaceutical Co (LJPC) |
|
|
$6.22 0.00 (0.00%) as of 4:30 Thu 8/18
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
27,470,000 |
| Market
Cap: |
170.86(M) |
| Last
Volume: |
2,592,323 |
Avg
Vol: |
2,568,054 |
| 52
Week Range: |
$6.22 - $6.22 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Fildes Robert Phd |
Director |
– • – |
2004-05-11 |
4 |
GA |
$0.00 |
$0 |
I/I |
16,801 |
16,801 |
|
- |
|
| Fildes Robert Phd |
Director |
– • – |
2004-05-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
16,801 |
66,263 |
|
- |
|
| Sloan Gail A |
VP of Finance/Controller |
• – – |
2004-04-12 |
4 |
B |
$2.72 |
$680 |
I/I |
250 |
250 |
1.91 |
- |
|
| Wiseman Andrew |
Sen Dir Investor Relations |
• – – |
2004-03-31 |
4 |
A |
$1.48 |
$768 |
D/D |
519 |
17,057 |
|
- |
|
| Welch William J |
VP Sales & Marketing |
• – – |
2004-03-31 |
4 |
A |
$2.35 |
$1,119 |
D/D |
477 |
893 |
|
- |
|
| Reilly Teddi |
VP of Human Resources |
• – – |
2004-03-31 |
4 |
A |
$1.48 |
$2,412 |
D/D |
1,631 |
17,405 |
|
- |
|
| Linnik Matthew D |
CSO & Exec VP of Research |
• – – |
2004-03-31 |
4 |
A |
$1.48 |
$1,516 |
D/D |
1,025 |
3,815 |
|
- |
|
| Jenn Paul |
VP of Product Development |
• – – |
2004-03-31 |
4 |
A |
$1.48 |
$904 |
D/D |
611 |
1,563 |
|
- |
|
| Heilbrunn Kenneth R |
VP of Clinical Development |
• – – |
2004-03-31 |
4 |
A |
$1.48 |
$1,386 |
D/D |
937 |
9,485 |
|
- |
|
| Bennett Bruce K Jr |
VP of Manufacturing |
• – – |
2004-03-31 |
4 |
A |
$1.48 |
$961 |
D/D |
650 |
36,424 |
|
- |
|
| Sloan Gail A |
VP of Finance/Controller |
• – – |
2004-03-31 |
4 |
A |
$1.48 |
$769 |
D/D |
520 |
12,398 |
|
- |
|
| Linnik Matthew D |
CSO & Exec VP of Research |
• – – |
2003-12-31 |
5 |
A |
$1.48 |
$751 |
D/D |
508 |
2,790 |
|
- |
|
| Sloan Gail A |
Sen Dir of Finance/Controller |
• – – |
2003-12-31 |
5 |
A |
$1.48 |
$432 |
D/D |
292 |
11,878 |
|
- |
|
| Jenn Paul |
VP of Product Development |
• – – |
2003-12-31 |
5 |
A |
$1.48 |
$488 |
D/D |
330 |
952 |
|
- |
|
| Heilbrunn Kenneth R |
VP of Clinical Development |
• – – |
2003-12-31 |
5 |
A |
$1.48 |
$1,813 |
D/D |
1,226 |
8,548 |
|
- |
|
| Reilly Teddi |
VP of Human Resources |
• – – |
2003-12-31 |
5 |
A |
$1.48 |
$2,434 |
D/D |
1,646 |
15,774 |
|
- |
|
| Welch William J |
VP Sales & Marketing |
• – – |
2003-12-31 |
5 |
A |
$2.77 |
$604 |
D/D |
218 |
416 |
|
- |
|
| Wiseman Andrew |
Sen Dir Business Development |
• – – |
2003-12-31 |
5 |
A |
$1.48 |
$430 |
D/D |
291 |
24,583 |
|
- |
|
| Bennett Bruce K Jr |
VP of Manufacturing |
• – – |
2003-12-31 |
5 |
A |
$1.48 |
$521 |
D/D |
352 |
35,774 |
|
- |
|
| Fildes Robert Phd |
Director |
– • – |
2003-12-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
83,064 |
|
- |
|
| Wiseman Andrew |
Sen Dir Business Development |
• – – |
2003-12-11 |
4 |
OE |
$1.00 |
$2,000 |
D/D |
2,000 |
24,292 |
|
- |
|
| Engle Steven B |
CEO & Chairman |
• • – |
2003-11-11 |
4 |
AS |
$2.93 |
$90,830 |
D/D |
(31,000) |
1,484 |
|
- |
|
| Engle Steven B |
CEO & Chairman |
• • – |
2003-11-11 |
4 |
OE |
$1.00 |
$31,000 |
D/D |
31,000 |
32,484 |
|
- |
|
| Engle Steven B |
CEO & Chairman |
• • – |
2003-11-10 |
4 |
AS |
$3.02 |
$332,200 |
D/D |
(110,000) |
1,484 |
|
- |
|
| Engle Steven B |
CEO & Chairman |
• • – |
2003-11-10 |
4 |
OE |
$1.00 |
$110,000 |
D/D |
110,000 |
111,484 |
|
- |
|
567 Records found
|
|
Page 22 of 23 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
